Mylan Specialty, Pfizer sign EpiPen Injection licensing deal in Japan
03:21 EDT 8 Aug 2012 | Pharmaceutical Business Review
Mylan Specialty, a subsidiary of Mylan, and Pfizer have signed a licensing contract for EpiPen Injection 0.3/0.15mg in Japan.
Original Article: Mylan Specialty, Pfizer sign EpiPen Injection licensing deal in Japan
More From BioPortfolio on "Mylan Specialty, Pfizer sign EpiPen Injection licensing deal in Japan"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
